Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands

Leukemia. 2021 Nov;35(11):3291-3294. doi: 10.1038/s41375-021-01174-9. Epub 2021 Feb 18.

Geneviève I C G Ector^{1

2}, Otto Visser³, Eduardus F M Posthuma^{4

5}, Peter E Westerweel⁶, Jeroen J W M Janssen⁷, Nicole M A Blijlevens⁸, Avinash G Dinmohamed^{9

7

10

11}

¹ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands. genevieve.ector@radboudumc.nl.
² Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. genevieve.ector@radboudumc.nl.
³ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁴ Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.
⁵ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
⁶ Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
⁷ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
⁸ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁹ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
¹⁰ Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
¹¹ Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

No abstract available

MeSH terms